Spero Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ANSON FUNDS MANAGEMENT LP | 11/15/2024 | 3.75 M | $5.03 M | 0.00% | 6.93% |
| VANGUARD GROUP INC | 11/13/2024 | 1.76 M | $2.36 M | -0.39% | 3.26% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 1.07 M | $1.44 M | 0.00% | 1.98% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 974,653 | $1.31 M | -0.13% | 1.80% |
| ALPHABET INC. | 11/08/2024 | 889,979 | $1.19 M | 0.00% | 1.64% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 743,459 | $996,235 | -19.10% | 1.37% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 484,820 | $649,660 | 100.00% | 0.90% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 481,187 | $644,939 | -2.23% | 0.89% |
| NOVO HOLDINGS A/S | 10/24/2024 | 468,902 | $628,329 | 0.00% | 0.87% |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 11/13/2024 | 402,885 | $539,866 | -24.74% | 0.74% |
| AWM INVESTMENT COMPANY, INC. | 11/14/2024 | 333,400 | $446,756 | 0.00% | 0.62% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 184,800 | $247,632 | 0.00% | 0.34% |
| STATE STREET CORP | 11/14/2024 | 130,511 | $174,885 | 0.00% | 0.24% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 125,000 | $167,500 | 0.00% | 0.23% |
| CITADEL ADVISORS LLC | 11/14/2024 | 81,425 | $109,109 | -73.91% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 44,219 | $59,253 | 91.65% | 0.08% |
| MAN GROUP PLC | 11/14/2024 | 38,481 | $51,565 | -47.62% | 0.07% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 32,172 | $43,110 | -67.34% | 0.06% |
| MACKENZIE FINANCIAL CORP | 11/13/2024 | 31,903 | $42,750 | -2.52% | 0.06% |
| DLK INVESTMENT MANAGEMENT, LLC | 10/09/2024 | 31,355 | $42,016 | 0.00% | 0.06% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 28,565 | $38,277 | 0.00% | 0.05% |
| SHAY CAPITAL LLC | 11/14/2024 | 25,000 | $33,500 | 0.00% | 0.05% |
| UBS GROUP AG | 11/14/2024 | 17,529 | $23,489 | 5,195.77% | 0.03% |
| PFG INVESTMENTS, LLC | 10/24/2024 | 13,979 | $18,732 | 100.00% | 0.03% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 10,003 | $13,404 | 0.00% | 0.02% |
| NATIONAL BANK OF CANADA /FI/ | 11/15/2024 | 10,000 | $13,400 | 100.00% | 0.02% |
| MORGAN STANLEY | 11/14/2024 | 6,971 | $9,341 | 0.00% | 0.01% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 6,400 | $8,576 | 0.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 5,654 | $7,576 | 1.73% | 0.01% |
| FMR LLC | 11/13/2024 | 3,139 | $4,206 | 8.65% | 0.01% |
| CIBC PRIVATE WEALTH GROUP, LLC | 11/13/2024 | 2,880 | $3,859 | 100.00% | 0.01% |
| WR WEALTH PLANNERS, LLC | 10/17/2024 | 2,600 | $3,484 | 0.00% | 0.00% |
| CULLEN/FROST BANKERS, INC. | 11/06/2024 | 2,000 | $2,680 | 0.00% | 0.00% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 921 | $1,000 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 295 | $395 | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 269 | $360 | -2.54% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 236 | $316 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 200 | $268 | -80.00% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 200 | $268 | -60.00% | 0.00% |
| CORECAP ADVISORS, LLC | 11/08/2024 | 192 | $257 | 0.00% | 0.00% |
| US BANCORP \DE\ | 10/28/2024 | 151 | $202 | 0.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 11/14/2024 | 100 | $134 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/12/2024 | 50 | $67 | 100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/13/2024 | 30 | $40 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| RHUMBLINE ADVISERS | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| TEXAS YALE CAPITAL CORP. | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 10/23/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Spero Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 63 institutional investors and hedge funds held shares of Spero Therapeutics, Inc.. The most heavily invested institutionals were:
Anson Funds Management LP: 3.75 M
VANGUARD GROUP INC: 1.76 M
ACADIAN ASSET MANAGEMENT LLC: 1.07 M
RENAISSANCE TECHNOLOGIES LLC: 974,653
Alphabet Inc.: 889,979
ADAR1 Capital Management, LLC: 743,459
22.75% of Spero Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 16.21 M shares in the last 24 months. This purchase volume represents approximately $15.23 M in transactions.